WO2023203380 - SPECTROPOLARIMETRIC IMAGING OF THE EYE FOR DISEASE DIAGNOSIS
National phase entry:
Publication Number
WO/2023/203380
Publication Date
26.10.2023
International Application No.
PCT/IB2023/000209
International Filing Date
20.04.2023
Title **
[English]
SPECTROPOLARIMETRIC IMAGING OF THE EYE FOR DISEASE DIAGNOSIS
[French]
IMAGERIE SPECTROPOLARIMÉTRIQUE DE L'ŒIL POUR LE DIAGNOSTIC DE MALADIES
Applicants **
RETISPEC INC.
Inventors
SHAKED, Eliav
HAZAN, Alon
ALTERINI, Tommaso
TEIKARI, Joni, Petteri
Priority Data
63/332,855
20.04.2022
US
63/425,155
14.11.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2916 | |
| EPO | Filing, Examination, Granting | 20120 | |
| Japan | Filing, Examination, Granting | 2618 | |
| South Korea | Filing, Examination, Granting | 3047 | |
| USA | Filing, Examination, Granting | 6540 |
Total:
35,241
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure is directed to an imaging system and methods of use thereof. The system can include a light source configured to emit light to illuminate a retina of an eye with the light. The system can include one or more imaging devices configured to receive light from the retina via one or more polarizers to generate one or more spectropolarimetric images of the retina. The system can include a computing device configured to receive the one or more spectropolarimetric images of the retina, evaluate the one or more spectropolarimetric images, and identify one or more biomarkers indicative of a pathology.[French]
La présente divulgation concerne un système d'imagerie et des procédés d'utilisation de celui-ci. Le système peut comprendre une source de lumière conçue pour émettre de la lumière pour éclairer une rétine d'un œil avec la lumière. Le système peut comprendre un ou plusieurs dispositifs d'imagerie conçus pour recevoir de la lumière de la rétine par l'intermédiaire d'un ou de plusieurs polariseurs pour générer une ou plusieurs images spectropolarimétriques de la rétine. Le système peut comprendre un dispositif informatique configuré pour recevoir la ou les images spectropolarimétriques de la rétine, évaluer la ou les images spectropolarimétriques et identifier un ou plusieurs biomarqueurs indiquant une pathologie.